SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-19-006664
Filing Date
2019-10-28
Accepted
2019-10-28 16:31:39
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 f102419010q.htm 10-Q 401799
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8875
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8767
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4991
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4798
  Complete submission text file 0001214659-19-006664.txt   2512364

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE hgen-20190930.xml EX-101.INS 343220
7 XBRL SCHEMA FILE hgen-20190930.xsd EX-101.SCH 41644
8 XBRL CALCULATION FILE hgen-20190930_cal.xml EX-101.CAL 38757
9 XBRL DEFINITION FILE hgen-20190930_def.xml EX-101.DEF 130049
10 XBRL LABEL FILE hgen-20190930_lab.xml EX-101.LAB 286908
11 XBRL PRESENTATION FILE hgen-20190930_pre.xml EX-101.PRE 201079
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 191173345
SIC: 2834 Pharmaceutical Preparations